{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "27241-086",
      "generic_name": "Amlodipine besylate and Olmesartan medoxomil",
      "labeler_name": "Ajanta Pharma USA Inc.",
      "brand_name": "Amlodipine besylate and Olmesartan medoxomil",
      "active_ingredients": [
        {
          "name": "AMLODIPINE BESYLATE",
          "strength": "10 mg/1"
        },
        {
          "name": "OLMESARTAN MEDOXOMIL",
          "strength": "40 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "27241-086-03",
          "description": "30 TABLET in 1 BOTTLE (27241-086-03)",
          "marketing_start_date": "20170206",
          "sample": false
        },
        {
          "package_ndc": "27241-086-09",
          "description": "90 TABLET in 1 BOTTLE (27241-086-09)",
          "marketing_start_date": "20170206",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Ajanta Pharma USA Inc."
        ],
        "rxcui": [
          "730861",
          "730866",
          "730869",
          "730872"
        ],
        "spl_set_id": [
          "69fa6293-b10a-4473-ab9b-1bd53f099bdd"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0327241085031",
          "0327241083037",
          "0327241084034",
          "0327241086038"
        ],
        "unii": [
          "6M97XTV3HD",
          "864V2Q084H"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "1c06acbb-7027-4b05-90a0-4f40c039c705",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20170206",
      "product_id": "27241-086_1c06acbb-7027-4b05-90a0-4f40c039c705",
      "application_number": "ANDA207216",
      "brand_name_base": "Amlodipine besylate and Olmesartan medoxomil",
      "pharm_class": [
        "Angiotensin 2 Receptor Antagonists [MoA]",
        "Angiotensin 2 Receptor Blocker [EPC]",
        "Calcium Channel Antagonists [MoA]",
        "Calcium Channel Blocker [EPC]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "Dihydropyridine Calcium Channel Blocker [EPC]",
        "Dihydropyridines [CS]"
      ]
    }
  ]
}